Nitecapone
Clinical data | |
---|---|
ATC code | None |
Identifiers | |
| |
CAS Number | 116313-94-1 |
PubChem (CID) | 5464105 |
ChemSpider | 4576539 |
Chemical and physical data | |
Formula | C12H11NO6 |
Molar mass | 265.219 g/mol |
3D model (Jmol) | Interactive image |
| |
|
Nitecapone (INN; OR-462) is a drug which acts as a selective inhibitor of the enzyme catechol O-methyl transferase (COMT).[1][2] It was patented as an antiparkinsonian agent but was never marketed.[1]
See also
References
- 1 2 F.. Macdonald (1997). Dictionary of Pharmacological Agents. CRC Press. p. 1635. ISBN 978-0-412-46630-4. Retrieved 20 May 2012.
- ↑ Nissinen E, Lindén IB, Schultz E, Kaakkola S, Männistö PT, Pohto P (August 1988). "Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat". European Journal of Pharmacology. 153 (2-3): 263–9. doi:10.1016/0014-2999(88)90614-0. PMID 3181288.
This article is issued from Wikipedia - version of the 10/16/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.